Skip to main content
NCBI home page
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 2001 Sep;71(3):296–302. doi: 10.1136/jnnp.71.3.296

Preclinical syndromes predict dementia: the Sydney older persons study

L Waite 1, G Broe 1, D Grayson 1, H Creasey 1
PMCID: PMC1737538  PMID: 11511700

Abstract

OBJECTIVES—To identify if preclinical syndromes for Alzheimer's disease, vascular dementia, and Parkinson's disease and related dementias exist. Identification of dementia at early or even preclinical stages has important implications for treatment.
METHODS—A community dwelling sample of 647 subjects aged 75 and over at recruitment were followed up for a mean period of 3.19 years (range 2.61 to 4.51 years). Each subject was asked to participate in a medical assessment which included a standardised medical history examining both past and current health and medication usage; a neuropsychological battery (mini mental state examination, Reid memory test, verbal fluency, subsets of the Boston naming test and similarities, clock drawing and copied drawings) and physical examination. Preclinical syndromes for the three predominant dementias (Alzheimer's disease, vascular dementia and Parkinson's disease, and related dementias) and their combinations were defined using cognitive, motor, and vascular features. Their longitudinal outcome as defined by death and dementia incidence was examined.
RESULTS—Preclinical syndromes affected 55.7% (n=299) of subjects. Preclinical syndromes showed a trend for an increased odds of death (odds ratio 1.72, p=0.056) and a significantly increased odds of developing dementia (odds ratio 4.81, p<0.001). Preclinical syndromes were highly sensitive, detecting 52 of 58 (89.7%) incident dementias. Two hundred and sixteen of 268 (80.6%) preclinical subjects did not show dementia over the 3 year period (positive predictive value 19.4%). Subjects defined as having a combination of cognitive, extrapyramidal, and vascular features were at greatest risk of progressing to dementia.
CONCLUSIONS—Preclinical syndromes were sensitive and significant predictors of dementia. In view of their poor positive predictive value, the preclinical syndromes as defined in this study remain a research tool needing both definitional refinement and greater periods of observation. Multiple coexistent preclinical disorders resulted in a greater incidence of dementia, providing evidence for an additive role between multiple disorders.



Full Text

The Full Text of this article is available as a PDF (171.2 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bennett D. A., Beckett L. A., Murray A. M., Shannon K. M., Goetz C. G., Pilgrim D. M., Evans D. A. Prevalence of parkinsonian signs and associated mortality in a community population of older people. N Engl J Med. 1996 Jan 11;334(2):71–76. doi: 10.1056/NEJM199601113340202. [DOI] [PubMed] [Google Scholar]
  2. Berg L., McKeel D. W., Jr, Miller J. P., Storandt M., Rubin E. H., Morris J. C., Baty J., Coats M., Norton J., Goate A. M. Clinicopathologic studies in cognitively healthy aging and Alzheimer's disease: relation of histologic markers to dementia severity, age, sex, and apolipoprotein E genotype. Arch Neurol. 1998 Mar;55(3):326–335. doi: 10.1001/archneur.55.3.326. [DOI] [PubMed] [Google Scholar]
  3. Breteler M. M., Claus J. J., Grobbee D. E., Hofman A. Cardiovascular disease and distribution of cognitive function in elderly people: the Rotterdam Study. BMJ. 1994 Jun 18;308(6944):1604–1608. doi: 10.1136/bmj.308.6944.1604. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Breteler M. M., van Amerongen N. M., van Swieten J. C., Claus J. J., Grobbee D. E., van Gijn J., Hofman A., van Harskamp F. Cognitive correlates of ventricular enlargement and cerebral white matter lesions on magnetic resonance imaging. The Rotterdam Study. Stroke. 1994 Jun;25(6):1109–1115. doi: 10.1161/01.str.25.6.1109. [DOI] [PubMed] [Google Scholar]
  5. Burns A., Luthert P., Levy R., Jacoby R., Lantos P. Accuracy of clinical diagnosis of Alzheimer's disease. BMJ. 1990 Nov 3;301(6759):1026–1026. doi: 10.1136/bmj.301.6759.1026. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Champion V. Breast self-examination in women 65 and older. J Gerontol. 1992 Nov;47(Spec No):75–79. [PubMed] [Google Scholar]
  7. Christensen H., Henderson A. S., Jorm A. F., Mackinnon A. J., Scott R., Korten A. E. ICD-10 mild cognitive disorder: epidemiological evidence on its validity. Psychol Med. 1995 Jan;25(1):105–120. doi: 10.1017/s0033291700028130. [DOI] [PubMed] [Google Scholar]
  8. Christensen H., Henderson A. S., Korten A. E., Jorm A. F., Jacomb P. A., Mackinnon A. J. ICD-10 mild cognitive disorder: its outcome three years later. Int J Geriatr Psychiatry. 1997 May;12(5):581–586. doi: 10.1002/(sici)1099-1166(199705)12:5<581::aid-gps571>3.0.co;2-b. [DOI] [PubMed] [Google Scholar]
  9. Cooper B., Bickel H., Schäufele M. Early development and progression of dementing illness in the elderly: a general-practice based study. Psychol Med. 1996 Mar;26(2):411–419. doi: 10.1017/s0033291700034802. [DOI] [PubMed] [Google Scholar]
  10. Corbett A., Bennett H., Kos S. Cognitive dysfunction following subcortical infarction. Arch Neurol. 1994 Oct;51(10):999–1007. doi: 10.1001/archneur.1994.00540220045013. [DOI] [PubMed] [Google Scholar]
  11. Crystal H. A., Dickson D., Sliwinski M., Masur D., Blau A., Lipton R. B. Associations of status and change measures of neuropsychological function with pathologic changes in elderly, originally nondemented subjects. Arch Neurol. 1996 Jan;53(1):82–87. doi: 10.1001/archneur.1996.00550010102023. [DOI] [PubMed] [Google Scholar]
  12. Ebly E. M., Hogan D. B., Parhad I. M. Cognitive impairment in the nondemented elderly. Results from the Canadian Study of Health and Aging. Arch Neurol. 1995 Jun;52(6):612–619. doi: 10.1001/archneur.1995.00540300086018. [DOI] [PubMed] [Google Scholar]
  13. Erkinjuntti T., Ostbye T., Steenhuis R., Hachinski V. The effect of different diagnostic criteria on the prevalence of dementia. N Engl J Med. 1997 Dec 4;337(23):1667–1674. doi: 10.1056/NEJM199712043372306. [DOI] [PubMed] [Google Scholar]
  14. Folstein M. F., Folstein S. E., McHugh P. R. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975 Nov;12(3):189–198. doi: 10.1016/0022-3956(75)90026-6. [DOI] [PubMed] [Google Scholar]
  15. Golomb J., Kluger A., de Leon M. J., Ferris S. H., Mittelman M., Cohen J., George A. E. Hippocampal formation size predicts declining memory performance in normal aging. Neurology. 1996 Sep;47(3):810–813. doi: 10.1212/wnl.47.3.810. [DOI] [PubMed] [Google Scholar]
  16. Gorelick P. B., Brody J., Cohen D., Freels S., Levy P., Dollear W., Forman H., Harris Y. Risk factors for dementia associated with multiple cerebral infarcts. A case-control analysis in predominantly African-American hospital-based patients. Arch Neurol. 1993 Jul;50(7):714–720. doi: 10.1001/archneur.1993.00540070034011. [DOI] [PubMed] [Google Scholar]
  17. Hachinski V., Graffagnino C., Beaudry M., Bernier G., Buck C., Donner A., Spence J. D., Doig G., Wolfe B. M. Lipids and stroke: a paradox resolved. Arch Neurol. 1996 Apr;53(4):303–308. doi: 10.1001/archneur.1996.00550040031011. [DOI] [PubMed] [Google Scholar]
  18. Hanninen T., Koivisto K., Reinikainen K. J., Helkala E. L., Soininen H., Mykkänen L., Laakso M., Riekkinen P. J. Prevalence of ageing-associated cognitive decline in an elderly population. Age Ageing. 1996 May;25(3):201–205. doi: 10.1093/ageing/25.3.201. [DOI] [PubMed] [Google Scholar]
  19. Hansen L., Salmon D., Galasko D., Masliah E., Katzman R., DeTeresa R., Thal L., Pay M. M., Hofstetter R., Klauber M. The Lewy body variant of Alzheimer's disease: a clinical and pathologic entity. Neurology. 1990 Jan;40(1):1–8. doi: 10.1212/wnl.40.1.1. [DOI] [PubMed] [Google Scholar]
  20. Haxby J. V., Grady C. L., Koss E., Horwitz B., Heston L., Schapiro M., Friedland R. P., Rapoport S. I. Longitudinal study of cerebral metabolic asymmetries and associated neuropsychological patterns in early dementia of the Alzheimer type. Arch Neurol. 1990 Jul;47(7):753–760. doi: 10.1001/archneur.1990.00530070043010. [DOI] [PubMed] [Google Scholar]
  21. Hänninen T., Hallikainen M., Koivisto K., Helkala E. L., Reinikainen K. J., Soininen H., Mykkänen L., Laakso M., Pyörälä K., Riekkinen P. J., Sr A follow-up study of age-associated memory impairment: neuropsychological predictors of dementia. J Am Geriatr Soc. 1995 Sep;43(9):1007–1015. doi: 10.1111/j.1532-5415.1995.tb05565.x. [DOI] [PubMed] [Google Scholar]
  22. Jacobs D. M., Marder K., Côté L. J., Sano M., Stern Y., Mayeux R. Neuropsychological characteristics of preclinical dementia in Parkinson's disease. Neurology. 1995 Sep;45(9):1691–1696. doi: 10.1212/wnl.45.9.1691. [DOI] [PubMed] [Google Scholar]
  23. Johansson B., Zarit S. H. Early cognitive markers of the incidence of dementia and mortality: a longitudinal population-based study of the oldest old. Int J Geriatr Psychiatry. 1997 Jan;12(1):53–59. doi: 10.1002/(sici)1099-1166(199701)12:1<53::aid-gps507>3.0.co;2-m. [DOI] [PubMed] [Google Scholar]
  24. Jorm A. F., Korten A. E., Henderson A. S. The prevalence of dementia: a quantitative integration of the literature. Acta Psychiatr Scand. 1987 Nov;76(5):465–479. doi: 10.1111/j.1600-0447.1987.tb02906.x. [DOI] [PubMed] [Google Scholar]
  25. Koivisto K., Reinikainen K. J., Hänninen T., Vanhanen M., Helkala E. L., Mykkänen L., Laakso M., Pyörälä K., Riekkinen P. J., Sr Prevalence of age-associated memory impairment in a randomly selected population from eastern Finland. Neurology. 1995 Apr;45(4):741–747. doi: 10.1212/wnl.45.4.741. [DOI] [PubMed] [Google Scholar]
  26. Linn R. T., Wolf P. A., Bachman D. L., Knoefel J. E., Cobb J. L., Belanger A. J., Kaplan E. F., D'Agostino R. B. The 'preclinical phase' of probable Alzheimer's disease. A 13-year prospective study of the Framingham cohort. Arch Neurol. 1995 May;52(5):485–490. doi: 10.1001/archneur.1995.00540290075020. [DOI] [PubMed] [Google Scholar]
  27. Minoshima S., Giordani B., Berent S., Frey K. A., Foster N. L., Kuhl D. E. Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease. Ann Neurol. 1997 Jul;42(1):85–94. doi: 10.1002/ana.410420114. [DOI] [PubMed] [Google Scholar]
  28. Morgante L., Rocca W. A., Di Rosa A. E., De Domenico P., Grigoletto F., Meneghini F., Reggio A., Savettieri G., Castiglione M. G., Patti F. Prevalence of Parkinson's disease and other types of parkinsonism: a door-to-door survey in three Sicilian municipalities. The Sicilian Neuro-Epidemiologic Study (SNES) Group. Neurology. 1992 Oct;42(10):1901–1907. doi: 10.1212/wnl.42.10.1901. [DOI] [PubMed] [Google Scholar]
  29. Morris J. C., Edland S., Clark C., Galasko D., Koss E., Mohs R., van Belle G., Fillenbaum G., Heyman A. The consortium to establish a registry for Alzheimer's disease (CERAD). Part IV. Rates of cognitive change in the longitudinal assessment of probable Alzheimer's disease. Neurology. 1993 Dec;43(12):2457–2465. doi: 10.1212/wnl.43.12.2457. [DOI] [PubMed] [Google Scholar]
  30. Morris J. C., Storandt M., McKeel D. W., Jr, Rubin E. H., Price J. L., Grant E. A., Berg L. Cerebral amyloid deposition and diffuse plaques in "normal" aging: Evidence for presymptomatic and very mild Alzheimer's disease. Neurology. 1996 Mar;46(3):707–719. doi: 10.1212/wnl.46.3.707. [DOI] [PubMed] [Google Scholar]
  31. O'Connor D. W., Pollitt P. A., Hyde J. B., Fellowes J. L., Miller N. D., Roth M. The progression of mild idiopathic dementia in a community population. J Am Geriatr Soc. 1991 Mar;39(3):246–251. doi: 10.1111/j.1532-5415.1991.tb01645.x. [DOI] [PubMed] [Google Scholar]
  32. O'Connor D. W., Pollitt P. A., Hyde J. B., Fellows J. L., Miller N. D., Roth M. A follow-up study of dementia diagnosed in the community using the Cambridge Mental Disorders of the Elderly Examination. Acta Psychiatr Scand. 1990 Jan;81(1):78–82. doi: 10.1111/j.1600-0447.1990.tb06453.x. [DOI] [PubMed] [Google Scholar]
  33. Perry R. H., Irving D., Blessed G., Fairbairn A., Perry E. K. Senile dementia of Lewy body type. A clinically and neuropathologically distinct form of Lewy body dementia in the elderly. J Neurol Sci. 1990 Feb;95(2):119–139. doi: 10.1016/0022-510x(90)90236-g. [DOI] [PubMed] [Google Scholar]
  34. Phillips N. A., Mate-Kole C. C. Cognitive deficits in peripheral vascular disease. A comparison of mild stroke patients and normal control subjects. Stroke. 1997 Apr;28(4):777–784. doi: 10.1161/01.str.28.4.777. [DOI] [PubMed] [Google Scholar]
  35. Pohjasvaara T., Erkinjuntti T., Vataja R., Kaste M. Dementia three months after stroke. Baseline frequency and effect of different definitions of dementia in the Helsinki Stroke Aging Memory Study (SAM) cohort. Stroke. 1997 Apr;28(4):785–792. doi: 10.1161/01.str.28.4.785. [DOI] [PubMed] [Google Scholar]
  36. Reid W., Broe G., Creasey H., Grayson D., McCusker E., Bennett H., Longley W., Sulway M. R. Age at onset and pattern of neuropsychological impairment in mild early-stage Alzheimer disease. A study of a community-based population. Arch Neurol. 1996 Oct;53(10):1056–1061. doi: 10.1001/archneur.1996.00550100142023. [DOI] [PubMed] [Google Scholar]
  37. Ritchie K., Touchon J. Mild cognitive impairment: conceptual basis and current nosological status. Lancet. 2000 Jan 15;355(9199):225–228. doi: 10.1016/S0140-6736(99)06155-3. [DOI] [PubMed] [Google Scholar]
  38. Rockwood K., Ebly E., Hachinski V., Hogan D. Presence and treatment of vascular risk factors in patients with vascular cognitive impairment. Arch Neurol. 1997 Jan;54(1):33–39. doi: 10.1001/archneur.1997.00550130019010. [DOI] [PubMed] [Google Scholar]
  39. Rubin E. H., Storandt M., Miller J. P., Kinscherf D. A., Grant E. A., Morris J. C., Berg L. A prospective study of cognitive function and onset of dementia in cognitively healthy elders. Arch Neurol. 1998 Mar;55(3):395–401. doi: 10.1001/archneur.55.3.395. [DOI] [PubMed] [Google Scholar]
  40. Skoog I., Berg S., Johansson B., Palmertz B., Andreasson L. A. The influence of white matter lesions on neuropsychological functioning in demented and non-demented 85-year-olds. Acta Neurol Scand. 1996 Feb-Mar;93(2-3):142–148. doi: 10.1111/j.1600-0404.1996.tb00190.x. [DOI] [PubMed] [Google Scholar]
  41. Skoog I., Lernfelt B., Landahl S., Palmertz B., Andreasson L. A., Nilsson L., Persson G., Odén A., Svanborg A. 15-year longitudinal study of blood pressure and dementia. Lancet. 1996 Apr 27;347(9009):1141–1145. doi: 10.1016/s0140-6736(96)90608-x. [DOI] [PubMed] [Google Scholar]
  42. Tatemichi T. K., Desmond D. W., Paik M., Figueroa M., Gropen T. I., Stern Y., Sano M., Remien R., Williams J. B., Mohr J. P. Clinical determinants of dementia related to stroke. Ann Neurol. 1993 Jun;33(6):568–575. doi: 10.1002/ana.410330603. [DOI] [PubMed] [Google Scholar]
  43. Troncoso J. C., Martin L. J., Dal Forno G., Kawas C. H. Neuropathology in controls and demented subjects from the Baltimore Longitudinal Study of Aging. Neurobiol Aging. 1996 May-Jun;17(3):365–371. doi: 10.1016/0197-4580(96)00028-0. [DOI] [PubMed] [Google Scholar]
  44. Waite L. M., Broe G. A., Creasey H., Grayson D. A., Cullen J. S., O'Toole B., Edelbrock D., Dobson M. Neurodegenerative and other chronic disorders among people aged 75 years and over in the community. Med J Aust. 1997 Oct 20;167(8):429–432. doi: 10.5694/j.1326-5377.1997.tb126655.x. [DOI] [PubMed] [Google Scholar]
  45. Waite L. M., Broe G. A., Creasey H., Grayson D., Edelbrock D., O'Toole B. Neurological signs, aging, and the neurodegenerative syndromes. Arch Neurol. 1996 Jun;53(6):498–502. doi: 10.1001/archneur.1996.00550060040013. [DOI] [PubMed] [Google Scholar]
  46. Waite L., Grayson D., Jorm A. F., Creasey H., Cullen J., Bennett H., Casey B., Broe G. A. Informant-based staging of dementia using the clinical dementia rating. Alzheimer Dis Assoc Disord. 1999 Jan;13(1):34–37. doi: 10.1097/00002093-199903000-00005. [DOI] [PubMed] [Google Scholar]
  47. Yoshitake T., Kiyohara Y., Kato I., Ohmura T., Iwamoto H., Nakayama K., Ohmori S., Nomiyama K., Kawano H., Ueda K. Incidence and risk factors of vascular dementia and Alzheimer's disease in a defined elderly Japanese population: the Hisayama Study. Neurology. 1995 Jun;45(6):1161–1168. doi: 10.1212/wnl.45.6.1161. [DOI] [PubMed] [Google Scholar]
  48. de Rijk M. C., Breteler M. M., Graveland G. A., Ott A., Grobbee D. E., van der Meché F. G., Hofman A. Prevalence of Parkinson's disease in the elderly: the Rotterdam Study. Neurology. 1995 Dec;45(12):2143–2146. doi: 10.1212/wnl.45.12.2143. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES